Features of the population immunity to SARS-CoV-2 development in staff members of medical organizations during the spread of COVID-19

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The ongoing COVID-19 pandemic generates the urgent need of monitoring the herd immunity among healthcare workers as a high-risk group for infection.

Aim. Determining the level and structure of population immunity to SARS-CoV-2 in the medical workers during the second peak of COVID-19 from August to November 2020.

Material and methods. The study involved 15,158 medical workers from 91 medical organizations of the Republic of Tatarstan. The age of the examined stuff members varied from 18 to 74 years, the average age was 45.48±0.1016 years, most of them were women (13 627, 89.87±0.258%). Testing for the presence of total antibodies (immunoglobulin classes G, A and M) to SARS- CoV-2 was performed once by the enhanced chemiluminescence method. Statistical processing was carried out by methods of variation statistics and correlation analysis according to the Pearson method using MS Excel and WinPepi.

Results. Seroprevalence to SARS-CoV-2 in medical workers was 35.23±0.388%. An increase in seropositive individuals level from 27.44±0.265% in August to 57.91±0.499% in November and an increase in the average geometric mean titer of total antibodies (immunoglobulin classes A, M, G) from 84.43 in August to 101.09 in November 2020 were detected. The level of individuals with antibodies increased with age from 18 to 59 years and decreased in group of 60–70 years. The largest proportion of seropositive to SARS-CoV-2 individuals was found among junior (42.01±1.384%) and middle grade (37.5±0.527%) medical staff of hospitals for patients with COVID-19, ambulance and emergency stations. Among the seropositive to the SARS-CoV-2 workers the proportion of asymptomatic forms of infection was 84.97±0.498%. According to the level of seroprevalence, municipal districts of the Republic of Tatarstan were divided into three groups: moderate — 8.9–39.0; average — 42.9–49.6, high level — 53.1–64.4.

Сonclusion. An increase in seroprevalence to SARS-CoV-2 was revealed among medical workers of the Republic of Tatarstan from August to November 2020 during the second peak of COVID-19.

Full Text

Restricted Access

About the authors

Marat N. Sadykov

Ministry of Health of the Republic of Tatаrstan

Email: Sadykov.Marat@tatar.ru
ORCID iD: 0000-0003-4890-1812

M.D., Cand. Sci. (Med.), Minister

Russian Federation, Kazan, Russia

Vasil B. Ziatdinov

Kazan Scientific Research Institute of Epidemiology and Microbiology

Email: kniem@mail.ru
ORCID iD: 0000-0001-8029-6515

M.D., Dr. Sci. (Med.), Director

Russian Federation, Kazan, Russia

Irina D. Reshetnikova

Kazan Scientific Research Institute of Epidemiology and Microbiology; Institute of Fundamental Medicine and Biology of Kazan Federal University

Author for correspondence.
Email: reshira@mail.ru
ORCID iD: 0000-0002-3584-6861

M.D., Cand. Sci. (Med.), Deputy Head, Kazan Scientific Research Institute of Epidemiology and Microbiology; Assoc. Prof.

Russian Federation, Kazan, Russia; Kazan, Russia

Niyaz M. Khakimov

Kazan State Medical University

Email: hakimniaz@gmail.com
ORCID iD: 0000-0001-7895-0012

M.D., Cand. Sci. (Med.), Assoc. Prof., Depart. of Epidemiology and Evidence-Based Medicine

Russian Federation, Kazan, Russia

Dmitriy V. Lopushov

Kazan State Medical University; Kazan State Medical Academy — Brunch of the Russian Medical Academy of Postgraduate Education

Email: doctor225@mail.ru
ORCID iD: 0000-0001-8896-969X

M.D., Cand. Sci. (Med.), Assoc. Prof., Depart. of Preventive Medicine and Human Ecology; Assoc. Prof., Depart. of Epidemiology and Disinfectology

Russian Federation, Kazan, Russia; Kazan, Russia

Guzel Sh. Isaeva

Kazan Scientific Research Institute of Epidemiology and Microbiology; Kazan State Medical University

Email: kniem@mail.ru
ORCID iD: 0000-0002-1462-8734

M.D., Dr. Sci. (Med.), Prof., Deputy Director for Innovative Development; Head, Depart. of Microbiology named after Academician V.M. Aristovsky

Russian Federation, Kazan, Russia; Kazan, Russia

References

  1. Fei Xiang, Xiaorong Wang, Xinliang He, Zhenghong Peng, Bohan Yang, Jianchu Zhang, Qiong Zhou, Hong Ye, Yanling Ma, Hui Li, Xiaoshan Wei, Pengcheng Cai, Wan-Li Ma. Antibody detection and dynamic characteristics in Patients with COVID-19. Clin Infect Dis. 2020;71(8):1930–1934. doi: 10.1093/cid/ciaa461.
  2. Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li, Shen Qian, Congming Hong, Fuxiang Wang , Yingxia Liu, Zhaoqin Wang, Qing He, Zhiyong Li, Bin He, Tianying Zhang, Yang Fu, Shengxiang Ge, Lei Liu, Jun Zhang, Ningshao Xia, Zheng Zhang. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–2034. doi: 10.1093/cid/ciaa344.
  3. Semenov AV, Pshenichnaya NY. Lessons to learn: COVID-19 epidemic in Italy. Russian Journal of Infection and Immunity. 2020;10(3):410–420. (In Russ.) doi: 10.15789/2220-7619-LTL-1468.
  4. The novel coronavirus pneumonia emergency response epidemiology team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases COVID-19. China CCDC Weekly. 2020;2(8):113–122.
  5. Liu T, Wu S, Tao H, Zeng G, Zhou F, Guo F, Wang X. Prevalence of IgG antibodies to SARS-CoV-2 in Wuhan — implications for the ability to produce long-lasting protective antibodies against SARS-CoV-2. medRxiv. 2020; 2020.06.13.20130252. doi: 10.1101/2020.06.13.20130252.
  6. Sotgiu G, Barassi A, Miozzo M, Saderi L, Piana A, Orfeo N, Colosio C, Felisati G, Davì M, Gerli GA, Centanni S. SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital. BMC Pulm Med. 2020;20:203. doi: 10.1186/s12890-020-01237-0.
  7. Popova AYu, Ezhlova EB, Melnikova AA, Bashketova NS, Fridman RK, Lyalina LV, Smir­nov VS, Chkhindzheria IG, Grechaninova TA, Agapov KA, Arsentyeva NA, Bazhenova NA, Batsunov OK, Danilova EM, Zueva EV, Komkova DV, Kuznetsova RN, Lyubimova NE, Markova AN, Khamitova IV, Lomonosova VI, Vetrov VV, Milichkina AM, Dedkov VG, Totolyan AA. Herd Immunity to SARS-CoV-2 among the Population in Saint-Petersburg during the COVID-19 Epidemic. Problems of Particularly Dangerous Infections. 2020;(3):124–130. (In Russ.) doi: 10.21055/0370-1069-2020-3-124-130.
  8. Popova AYu, Ezhlova EB, Mel’nikova AA, Historik OA, Mose­vich OS, Lyalina LV, Smirnov VS, Cherny MA, Balabysheva NS, Loginova IS, Vladimirova OS, Samoglyadova IS, Vasev NA, Rumyantseva SV, Chupalova EYu, Selivanova GV, Muraviova MV, Timofeeva LV, Khankishieva EN, Tylchevskaya VD, Nikitenko ND, Kostenitskaya TI, Virkunen NV, Klimkina IM, Kuzmina TM, Degtyarenko NV, Bazunova AI, Filippova LA, Palchikova NA, Kukshkin AV, Arsentieva NA, Batsunov OK, Bogumilchik EA, Voskresenskaya EA, Drobyshevskaya VG, Zueva EV, Kokorina GI, Kurova NN, Lyubimova NE, Ferman RS, Khamdulaeva GN, Khamitova IV, Khorkova EV, Milichkina AM, Dedkov VG, Totolian AA. Assessment of the Herd Immunity to SARS-CoV-2 among the Population of the Leningrad Region during the COVID-19 Epidemic. Problems of Particularly Dangerous Infections. 2020;(3):114–123. (In Russ.) doi: 10.21055/0370-1069-2020-3-114-123.
  9. Popova AYu, Ezhlova EB, Melnikova AA, Kutyrev VV, Kozhanova OI, Cherkasskaya TS, Lyalina VI, Smirnov VS, Bugorkova SA, Portenko SA, Naydenova EV, Shcherbakova SA, Lomonosova VI, Totolyan AA. Characteristics of the Herd Immunity to SARS-CoV-2 in Residents of the Saratov Region under COVID-19 Epidemic. Problems of Particularly Dangerous Infections. 2020;(4):106–116. (In Russ.) doi: 10.21055/0370-1069-2020-4-106-116.
  10. Popova AYu, Ezhlova EB, Melnikova AA, Stepanova TF, Sharukho GV, Letyushev AN, Volmer AYa, Shepotkova FF, Lyalina LV, Smirnov VS, Stepanova KB, Panina TA, Sidorovna ON, Okhotnikova EV, Stakhova EG, Totolian AA. Distribution of SARS-CоV-2 seroprevalence among residents of the Tyumen Region during the COVID-19 epidemic period. Journal of micro­biology, epidemiology and immunobiology. 2020;97(5):392–400. (In Russ.) doi: 10.36233/0372-9311-2020-97-5-1.
  11. Popova AYu, Ezhlova EB, Melnikova AA, Trotsenko OE, Zaitseva TA, Lyalina LV, Garbuz YuA, Smirnov VS, Lomonosova VI, Balakhontseva LA, Kotova VO, Bazykina EA, Butakova LV, Sapega EYu, Aleinikova NV, Bebenina LA, Loseva SM, Karavyanskaya TN, Totolyan AA. The seroprevalence of SARS-CoV-2 among residents of the Khabarovsk Krai during the COVID-19 epidemic. Journal of microbiology, epidemiology and immunobiology. 2021;98(1):7–17. (In Russ.) doi: 10.36233/0372-9311-92.
  12. Vremennyye metodicheskie rekomendatsii “Profilaktika, diagnostika i lechenie novoy koronavirusnoy infekcii (COVID-19)”. (Interim guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)”.) Ministry of Health of the Russian Federation. Version 10 (02/08/2021). 261 р. (In Russ.)
  13. Protocol for a population-based age-stratified sero-epidemiological study of COVID-19 infection in humans. Version 2.0 Date: May 26, 2020. WHO/2019-nCoV/Seroepidemiology/2020.2. https://apps.who.int/iris/handle/10665/332188 (access date: 30.05.2021).
  14. Popova AYu, Andreeva EE, Babura EA, Balakhonov SV, Bashketova NS, Bulanov MV, Valeullina NN, Goryaev DV, Detkovskaya NN, Ezhlova EB, Zaitseva NN, Historian OA, Kovalchuk IV, Kozlovskikh DN, Kombarova SV, Kurganova OP, Kuty­rev VV, Lomovtsev AE, Lukicheva LA, Lyalina LV, Melnikova AA, Mikailova OM, Noskov AK, Noskova LN, Oglezneva EE, Osmolovskaya TP, Patyashina MA, Penkovskaya NA, Samoilova LV, Smirnov VS, Stepanova TF, Trotsenko OE, Totolyan AA. Features of develo­ping SARS-CoV-2 nucleocapsid protein population-based seroprevalence during the first wave of the COVID-19 ­epidemic in the Russian Federation. Russian Journal of Infection and Immunity. 2021;11(2):297–323. (In Russ.) doi: 10.15789/2220-7619-FOD-1684.
  15. Report of the head of the Rospotrebnadzor for the Republic of Tatarstan M.A. Patyashina at a meeting of the final board of the Office of Rospotrebnadzor in the Republic of Tatarstan on January 20, 2021. https://tatarstan.ru/press/video.htm/video/7016439.htm (access date: 29.0.2021). (In Russ.)
  16. Smirnov VS, Zarubaev VV, Petlenko SV. Biology of pathogens and control of influenza and ARVI. Saint Petersburg: Hippocrates; 2020. 296 р. (In Russ.)
  17. Al-Tawfiq JA. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19). Travel Med Infect Dis. 2020;35:101608. doi: 10.1016/j.tmaid.2020.
  18. Gao Z, Xu Y, Sun C, Chao Sun, Wang X, Guo Y, Qiu S, Ma K. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021;54(1):12–16. doi: 10.1016/j.jmii.2020.05.001.
  19. Popova АYu, Ezhlova EB, Melnikova AA, Patyashina MA, Sizova EP, Yuzlibaeva LR, Lyalina LV, Smirnov VS, Badamshina GG, Goncharova AV, Arbuzova TV, Lomonosova VI, Totolyan AA. Distribution of SARS-CоV-2 seroprevalence among residents of the Republic of Tatarstan during the COVID-19 epidemic period. Journal of microbiology, epidemiology and immunobiology. 2020;97(6):518–528. (In Russ.) doi: 10.36233/0372-9311-2020-97-6-2.

Supplementary files

Supplementary Files
Action
1. Рис. 1. Динамика уровней серопревалентности с августа по ноябрь 2020 г. среди работников медицинских организаций муниципальной собственности Республики Татарстан; по оси ординат — серопревалентность (%), по оси абсцисс — месяцы

Download (22KB)
2. Рис. 2. Динамика среднегеометрического титра антител с августа по ноябрь 2020 г. среди серопозитивных работников медицинских организаций муниципальной собственности Республики Татарстан; по оси ординат — среднегеометрический титр антител, по оси абсцисс — месяцы

Download (13KB)
3. Рис. 3. Корреляционная связь между серопревалентностью и напряжённостью иммунитета к SARS-CoV-2 у работников медицинских организаций муниципальной собственности Республики Татарстан (метод — по Пирсону); по оси ординат — среднегеометрический титр антител, по оси абсцисс — серопревалентность (%)

Download (10KB)
4. Рис. 4. Серопревалентность к SARS-CoV-2 медицинских работников муниципальных районов Республики Татарстан с августа по ноябрь 2020 г.

Download (121KB)
5. Рис. 5. Доля лиц с бессимптомными формами из общего числа серопозитивных к SARS-CoV-2 медицинских работников медицинских организаций Республики Татарстан в августе — ноябре 2020 г.; по оси ординат — доля лиц с бессимптомными формами от всех серопозитивных (%), по оси абсцисс — возраст (годы)

Download (20KB)

© 2022 Eco-Vector





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies